First Time Loading...
Y

Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675

Watchlist Manager
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Watchlist
Price: 13.17 CNY -2.15% Market Closed
Updated: May 13, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Yantai Dongcheng Biochemicals Co Ltd

Wall Street analysts forecast Yantai Dongcheng Biochemicals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Yantai Dongcheng Biochemicals Co Ltd is 20.3 CNY with a low forecast of 17.98 CNY and a high forecast of 23.1 CNY.

Lowest Forecast
Wall Street Target
17.98 CNY
37% Upside
Average Forecast
Wall Street Target
20.3 CNY
54% Upside
Highest Forecast
Wall Street Target
23.1 CNY
75% Upside
Lowest
Price Target
17.98 CNY
37% Upside
Average
Price Target
20.3 CNY
54% Upside
Highest
Price Target
23.1 CNY
75% Upside
Yantai Dongcheng Biochemicals Co Ltd Competitors:
Price Targets
MOR
MorphoSys AG
15% Downside
RNA
Avidity Biosciences Inc
80% Upside
TGTX
TG Therapeutics Inc
97% Upside
IDYA
IDEAYA Biosciences Inc
31% Upside
MOR
MorphoSys AG
15% Downside
RNA
Avidity Biosciences Inc
80% Upside
TGTX
TG Therapeutics Inc
97% Upside
IDYA
IDEAYA Biosciences Inc
31% Upside
ICCC
ImmuCell Corp
157% Upside
UTHR
United Therapeutics Corp
16% Upside
B
002038
Beijing SL Pharmaceutical Co Ltd
397% Upside
ZYME
Zymeworks Inc
67% Upside

Revenue
Forecast

Revenue Estimate
Yantai Dongcheng Biochemicals Co Ltd

For the last 8 years the compound annual growth rate for Yantai Dongcheng Biochemicals Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 12%.

19%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Yantai Dongcheng Biochemicals Co Ltd

For the last 8 years the compound annual growth rate for Yantai Dongcheng Biochemicals Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 27%.

17%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-28%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Yantai Dongcheng Biochemicals Co Ltd

For the last 8 years the compound annual growth rate for Yantai Dongcheng Biochemicals Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 25%.

11%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Yantai Dongcheng Biochemicals Co Ltd's stock price target?
Price Target
20.3 CNY

According to Wall Street analysts, the average 1-year price target for Yantai Dongcheng Biochemicals Co Ltd is 20.3 CNY with a low forecast of 17.98 CNY and a high forecast of 23.1 CNY.

What is Yantai Dongcheng Biochemicals Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Yantai Dongcheng Biochemicals Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 12%.

What is Yantai Dongcheng Biochemicals Co Ltd's Operating Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Yantai Dongcheng Biochemicals Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 27%.

What is Yantai Dongcheng Biochemicals Co Ltd's Net Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Yantai Dongcheng Biochemicals Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 25%.

ALPHA SPREAD
Join more than 136,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.